- Home
- REI vs RNAC Comparison
REI vs RNAC Comparison
Compare REI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REI | RNAC |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.3M | 175.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | REI | RNAC |
|---|---|---|
| Price | $0.99 | $7.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.80 |
| AVG Volume (30 Days) | ★ 1.5M | 177.2K |
| Earning Date | 03-04-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $308,790,652.00 | $1,091,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $5.98 |
| 52 Week High | $1.51 | $20.00 |
Technical Indicators
Market Signals| Indicator | REI | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 64.94 | 52.15 |
| Support Level | $0.93 | $7.18 |
| Resistance Level | $1.01 | $7.63 |
| Average True Range (ATR) | 0.05 | 0.54 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 87.79 | 60.75 |
Price Performance
Historical ComparisonAbout REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.